Position in NVS
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$851,733
+$109,580 QoQ
Shares Held
5,576
+3.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 6%
Shared 0%
None 94%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Parkside Financial Bank & Trust holds $28,780,130 across 15 Drug Manufacturers - General names. NVS ranks #8 (3.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
7,749 | $7,127,297 | |
| 2 | ABBV |
AbbVie Inc.
|
28,631 | $6,226,955 | |
| 3 | JNJ |
Johnson & Johnson
|
20,434 | $4,994,886 | |
| 4 | MRK |
Merck & Co., Inc.
|
25,825 | $3,106,488 | |
| 5 | PFE |
Pfizer Inc
|
72,976 | $2,049,165 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
27,005 | $1,637,853 | |
| 7 | AMGN |
Amgen Inc
|
3,990 | $1,403,881 | |
| 8 | NVS |
Novartis AG
This page
|
5,576 | $851,733 |
All Filings in NVS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $851,733 | 5,576 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $742,153 | 5,383 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $588,235 | 4,587 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $559,429 | 4,623 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $496,865 | 4,457 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $361,506 | 3,715 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $424,768 | 3,693 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $424,349 | 3,986 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $403,073 | 4,167 | Shares | Sole | 2024-05-01 | |
| 2023-12-31 | $546,549 | 5,413 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $311,487 | 3,058 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $308,581 | 3,058 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $289,800 | 3,150 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $289,305 | 3,189 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $239,430 | 3,150 | Shares | Sole | 2022-11-01 | |
| 2022-06-30 | $269,227 | 3,185 | Shares | Sole | 2022-07-13 | |
| 2022-03-31 | $278,606 | 3,175 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $269,932 | 3,086 | Shares | Defined | 2022-03-01 | |
| 2021-09-30 | $305,284 | 3,733 | Shares | Defined | 2021-10-29 | |
| 2021-06-30 | $338,408 | 3,709 | Shares | Defined | 2021-08-06 | |
| 2021-03-31 | $305,248 | 3,571 | Shares | Defined | 2021-05-10 | |
| 2020-12-31 | $351,184 | 3,719 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $312,098 | 3,589 | Shares | Defined | 2020-11-06 | |
| 2020-06-30 | $439,232 | 5,029 | Shares | Defined | 2020-08-10 | |
| 2020-03-31 | $419,257 | 5,085 | Shares | Defined | 2020-05-05 | |
| No filing history on record for this holder in this stock. | ||||||